Skip to main content

Innovation Pharmaceuticals Inc.

IPIXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001355250

Innovation Pharmaceuticals Inc. was delisted in 2025; its insiders filed their last Form 4 on Jan 4, 2023; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Holders of 5% or more of IPIX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Innovation Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Innovation Pharmaceuticals Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on Innovation Pharmaceuticals Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IPIX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 5, 2022Kips Bay Select LP13G/AOld format–––SEC
May 3, 2021Kips Bay Select LP13G/AOld format–––SEC
Feb 11, 2021Kips Bay Select LP13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Innovation Pharmaceuticals Inc. shares.

No Form 144 notices for Innovation Pharmaceuticals Inc. are on file.